Smith Mark Alan 4
4 · VistaGen Therapeutics, Inc. · Filed Sep 20, 2017
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2017-09-19+100,000→ 100,000 totalExercise: $1.56Exp: 2027-09-19→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1/3rd of the total number of shares shall be immediately vested upon the Vesting Start Date, 9/19/2017, and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years from the Vesting Start Date.